PS Ratio Chart

View PS Ratio for NNCSF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View PS Ratio Chart
Start Trial

Historical PS Ratio Data

View and export this data back to 2010. Start Trial.
Date Value
August 25, 2026 5.144
August 24, 2026 5.144
August 21, 2026 5.144
August 20, 2026 5.144
August 19, 2026 5.144
August 18, 2026 4.898
August 17, 2026 4.898
August 14, 2026 4.898
August 13, 2026 4.898
August 12, 2026 4.898
August 11, 2026 4.898
August 10, 2026 4.898
August 07, 2026 4.898
August 06, 2026 4.898
August 05, 2026 4.898
August 04, 2026 4.898
August 03, 2026 4.898
July 31, 2026 4.898
July 30, 2026 4.898
July 29, 2026 4.898
July 28, 2026 4.898
July 27, 2026 4.898
July 24, 2026 4.898
July 23, 2026 4.898
July 22, 2026 4.887
Date Value
July 21, 2026 4.887
July 20, 2026 5.703
July 17, 2026 5.703
July 16, 2026 5.703
July 15, 2026 5.703
July 14, 2026 5.703
July 13, 2026 5.703
July 10, 2026 5.703
July 09, 2026 5.703
July 08, 2026 5.703
July 07, 2026 5.703
July 06, 2026 5.703
July 02, 2026 5.703
July 01, 2026 5.703
June 30, 2026 5.703
June 29, 2026 5.896
June 26, 2026 5.896
June 25, 2026 5.896
June 24, 2026 5.896
June 23, 2026 5.896
June 22, 2026 5.896
June 18, 2026 5.456
June 17, 2026 5.456
June 16, 2026 5.456
June 15, 2026 5.456

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
Cochlear Ltd. 4.086
ImpediMed Ltd. 0.8843
Somnomed Ltd. 1.268
Imagion Biosystems Ltd. --
Micro-X Ltd. 2.692

PS Ratio Related Metrics